Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03859440
Other study ID # HOYA-3601
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2019
Est. completion date October 2019

Study information

Verified date March 2019
Source HOYA Lamphun Ltd
Contact Atsushi Uchida
Phone +81 3 5913 2378
Email atsushi.uchida@hoya.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the clinical performance of two daily disposable silicone hydrogel contact lenses. One of these lenses, the 'test' lens is an investigational product. This means that it has not yet been approved for commercial use and is not available for sale. The other lens (control) is a commercially available contact lens.

The results of this study will be analysed to determine how the 'test' lens compares with the 'control' lens. The control lens has been chosen because it is a market leader and is well tried and tested.

Participants who are in this study will need to have healthy eyes, except for the need to correct their eyesight. Up to 90 people who are aged 20 years or older will be considered for participation in this study. The study is designed to be approximately 3 months long.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date October 2019
Est. primary completion date October 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Be aged 20 years or more.

- Sign written informed consent.

- Be a currently adapted soft contact lens wearer (i.e. be wearing lenses at least 1 month prior to enrolment).

- Contact lens sphere requirement between -1.00 to -6.00 D (inclusive).

- Refractive astigmatism (if present) less than or equal to 0.75 D in both eyes.

- Be correctable by sphero-cylindrical refraction to 6/7.5 (+0.10 logMAR 0.8 decimal) or better in each eye.

- Require visual correction in both eyes (monovision allowed, no monofit.

Exclusion Criteria:

- Require toric or multifocal contact lenses.

- Concurrent ocular medication.

- Using systemic or topical medications that will in the investigator's opinion affect ocular physiology or contact lens performance.

- Any systemic illness affecting contact lens wear or the medical treatment of which would affect vision or successful lens wear (including diabetes).

- Clinically significant (=Grade 2) corneal staining, corneal edema, corneal vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.

- History of herpetic keratitis.

- Pathological dry eye.

- Aphakia or amblyopia.

- History of refractive surgery, keratoconus or other corneal irregularity.

- Pregnancy, lactating or planning a pregnancy at the time of enrolment.

- Participation in any concurrent clinical trial or within the last 30 days.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
DSiHy Silicone hydrogel soft contact lens
•Device: DSiHy (test lens) Silicone hydrogel soft contact lens for daily disposable wear.
CE-marked Silicone hydrogel soft contact lens
·Device: Silicone hydrogel soft contact lens CE-marked for daily disposable wear. Other Name : MyDay

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
HOYA Lamphun Ltd

Outcome

Type Measure Description Time frame Safety issue
Primary Lens-related ocular adverse events requiring temporary or permanent discontinuation (resting eyes) as a proportion of follow-up eye examinations. 13 week visit
Primary Proportion of eyes with visual acuity corrected to 6/6 or better (1.0 decimal) at each visit. 13 week visit
Primary Proportion of eyes with best sphere-corrected visual acuity of 6/6 or better (1.0 decimal) at each visit. 13 week visit
Secondary The following variables will be compared between lens types: Corneal staining - type (mean grade, 0-4) Assessed by sector with fluorescein, blue light, yellow filter and full beam using medium magnification.
0 NONE: No staining
Micropunctate - Punctate staining, minor localized or scattered in on one or two quadrants
Macropunctate - Coalescent punctate staining, localized in one or two quadrants
Widespread coalescent punctate staining in more than two quadrants
Confluent staining or erosion (usually accompanied by hyperemia)
13 week visit
Secondary The following variables will be compared between lens types: Limbal hyperemia (grade, 0-4) Assessed using slit lamp with white light, low-medium magnification 0 NONE: No injection present
TRACE: Slight limbal (mild segmented), bulbar (mild regional), and/or palpebral injection
MILD: Mild limbal (mild circumcorneal), bulbar (mild diffuse) injection
MODERATE: Significant limbal (marked segmented), bulbar (marked regional or diffuse) injection
SEVERE: Severe limbal (marked circumcorneal), bulbar (diffuse episcleral or scleral) injection
13 week visit
Secondary The following variables will be compared between lens types: Bulbar hyperemia (grade, 0-4). Assessed using slit lamp with white light, low-medium magnification 0 NONE: No injection present
TRACE: Slight limbal (mild segmented), bulbar (mild regional), and/or palpebral injection
MILD: Mild limbal (mild circumcorneal), bulbar (mild diffuse) injection
MODERATE: Significant limbal (marked segmented), bulbar (marked regional or diffuse) injection
SEVERE: Severe limbal (marked circumcorneal), bulbar (diffuse episcleral or scleral) injection
13 week visit
Secondary The following variables will be compared between lens types: Comfort (0-10) Assessed by subject. 0 to 10 scale 10 = cannot be felt 0 = painful 13 week visit
Secondary The following variables will be compared between lens types: Visual acuity (logMAR VA) 13 week visit
Secondary The following variables will be compared between lens types: Wettability (0-4). Lens surface wettability rated on the appearance of the lens surface and the drying time viewed with a slit lamp under low magnification.
0 VERY POOR: Immediately displaying non-wetting areas on lens surface.
POOR: Irregular surface appearance; drying time ACCEPTABLE: Smooth surface appearance immediately after the blink becoming irregular with time; drying time >interblink period.
GOOD: Typical lens appearance with long drying time.
EXCELLENT: Appearance of a healthy cornea with very long drying time.
13 week visit
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05433259 - Biometric Factors Changes Caused by Myopia Orthokeratology (OK) Lens N/A
Completed NCT00940459 - Subjective and Conjunctival Response to Edge Design of Different Silicone Hydrogels N/A
Completed NCT02921087 - Connecting Contact Lenses and Digital Technology N/A
Completed NCT01192126 - A Study to Evaluate the Product Performance of a Daily Disposable Contact Lens N/A
Completed NCT00982046 - A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses N/A